Wall Street analyst estimates for Profound Medical Corp. (PROF): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Profound Medical Corp., through its subsidiaries, is a commercial-stage medical technology firm specializing in the development of magnetic resonance (MR)-guided ablation solutions. These innovative procedures are designed to treat conditions such as prostate disease and uterine fibroids, as well as providing palliative pain relief. The company markets its solutions across Canada, Germany, the United States, and Finland.
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-11-12 | $-0.23 | ||
| 2026-08-06 | $-0.26 | $-0.22 | -18.2% |
| 2026-05-07 | $-0.19 | $-0.24 | +20.8% |
| 2026-03-05 | $-0.27 | $-0.27 | +0.0% |
| 2025-11-13 | $-0.26 | $-0.38 | +31.6% |
| 2025-08-14 | $-0.52 | $-0.43 | -20.9% |
| 2025-05-08 | $-0.36 | $-0.29 | -24.1% |
| 2025-03-06 | $-0.20 | $-0.31 | +35.5% |
Valuation Ratios
| Price / Book | 4.06 |
| EV / EBITDA | -5.25 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | $4.9M | $1.9M | $4.2M | $7.3M | $6.9M | $6.7M | $7.2M | $10.2M | $16.4M |
| Cost of Revenue | $188385 | $3.0M | $1.3M | $1.8M | $3.8M | $3.9M | $3.7M | $2.8M | $3.5M | $4.8M |
| Gross Profit | -$188385 | $1.9M | $604815 | $2.4M | $3.5M | $3.0M | $3.0M | $4.4M | $6.7M | $11.6M |
| Research & Development | $7.4M | $7.7M | $7.5M | $9.4M | $9.9M | $15.3M | $14.7M | $14.4M | $16.2M | $21.0M |
| Selling, General & Admin | $4.2M | $7.8M | $7.9M | $7.9M | $12.4M | $18.0M | $17.9M | $18.6M | $22.0M | $32.6M |
| Operating Expenses | $16.2M | $19.1M | $15.4M | $17.3M | $22.3M | $33.2M | $35.1M | $33.0M | $38.2M | $53.6M |
| Operating Income | -$16.2M | -$17.2M | -$14.8M | -$14.9M | -$18.9M | -$30.3M | -$32.1M | -$28.6M | -$31.5M | -$42.0M |
| EBITDA | -$15.6M | -$16.5M | -$19.5M | -$12.5M | -$19.5M | -$28.6M | -$26.6M | -$26.8M | -$25.6M | -$41.4M |
| Interest Expense | $615868 | $1.1M | $755374 | $1.0M | $543000 | $66410 | $167105 | $770000 | 0 | 0 |
| Pre-tax Income | -$16.3M | -$18.7M | -$15.1M | -$15.1M | -$21.6M | -$30.6M | -$28.4M | -$28.7M | -$26.5M | -$43.1M |
| Income Tax | $14054 | $74123 | $169441 | $147000 | $45000 | $105000 | $287000 | -$128000 | -$1903 | $256411 |
| Net Income | -$12.1M | -$19.1M | -$15.2M | -$15.2M | -$21.6M | -$30.7M | -$28.7M | -$28.6M | -$26.5M | -$43.3M |
| EPS | $-3.93 | $-2.44 | $-1.52 | $-1.39 | $-1.25 | $-1.50 | $-1.38 | $-1.35 | $-1.07 | $-1.43 |
| EPS (Diluted) | $-3.93 | $-2.44 | $-1.52 | $-1.39 | $-1.25 | $-1.50 | $-1.38 | $-1.35 | $-1.07 | $-1.43 |
| Shares Outstanding (Diluted) | $4.2M | $6.1M | $10.0M | $11.1M | $17.3M | $20.5M | $20.8M | $21.2M | $24.8M | $30.2M |
Price
| Price | $5.89 |
| Market Cap | $214M |
| Exchange | NASDAQ |
| Country | CA |
Related companies: ARMP · AVR · CATX · LNSR · MXCT · NNOX · OWLT
Explore sector: Healthcare · Medical - Devices
More sections of PROF: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks